Silk Road Medical to Present at the CL King 21st Annual Best Ideas Conference
04 Septiembre 2023 - 3:30PM
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on
reducing the risk of stroke and its devastating impact, today
announced that management will present at the CL King 21st Annual
Best Ideas Conference.
Management is scheduled to present on Monday,
September 18, 2023, at 8:45 a.m. Pacific Time. Interested parties
may access a live and archived webcast of the presentation on the
“Investors” section of the company’s website
at: https://investors.silkroadmed.com/.
About Silk Road MedicalSilk Road Medical, Inc.
(NASDAQ: SILK), is a medical device company located in Sunnyvale,
California, and Plymouth, Minnesota, that is focused on reducing
the risk of stroke and its devastating impact. The company has
pioneered a new approach for the treatment of carotid artery
disease called TransCarotid Artery Revascularization (TCAR). TCAR
is a clinically proven procedure combining surgical principles of
neuroprotection with minimally invasive endovascular techniques to
treat blockages in the carotid artery at risk of causing a stroke.
For more information on how Silk Road Medical is delivering
brighter patient outcomes through brighter clinical thinking, visit
www.silkroadmed.com and connect on Twitter, LinkedIn and
Facebook.
Investor Contact:Lynn Lewis or Marissa
BychGilmartin Groupinvestors@silkroadmed.com
Media:Michael FanucchiSilk Road
Medicalmfanucchi@silkroadmed.com
Silk Road Medical (NASDAQ:SILK)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Silk Road Medical (NASDAQ:SILK)
Gráfica de Acción Histórica
De May 2023 a May 2024